

Equity outlook: Lovely liquidity
It’s been a stunning 2024 for equities, led by the US, but emerging markets also delivered solid gains and may be primed for more in 2025 if Trump trade dispute fears can be overcome.
概要
- Equity market strength surprised in 2024, with the US and China both beating expectations
- Our Global Stars team benefited from the AI-driven rally and some unheralded quality gems
- We are positive on EM in 2025 once potential Trump tariffs move to a negotiation phase
For the last 25 years I have organized investment forecasting games in the office. Usually, around 60% of participating colleagues are on the right side of the market. This year has been exceptional, as the vast majority of participants have underestimated the strength of the markets. The S&P 500, Chinese equities, Magnificent Seven stocks and credit spreads have all performed much better than was anticipated at the beginning of the year. The number of risks seemed endless: market concentration, highly valued technology stocks, prolonged inflation with a Fed behind the curve, China in the doldrums, just to name a few. Who would have expected one of the strongest equity markets of this century, with almost 30% return [MSCI World in EUR on 16 December] at the time of writing? Stanley Druckenmiller’s investment adage was once again proven true: it’s liquidity that moves markets. Particularly so when the real economy has a limited number of projects to absorb the (excess) capital.
Luckily, our Fundamental Equity teams looked beyond the risks and captured opportunities across the spectrum. The Global Stars team kept the foot on the pedal of large-cap technology stocks and benefited from the AI-powered rally. That took courage; good value is not always to be found in cheap stocks. At the same time the team invested in multiple other successful companies, such as Trane Technologies, Deutsche Telecom and Paypal. The performance record of the Global Stars strategy relative to the benchmark is very strong over a 1-, 3-, 5- and 10-year horizon, and we welcomed numerous new clients over the course of 2024. The portfolio positioning looks promising for 2025.
Emerging markets are up a healthy 15% year-to-date. The strong relative performance of our Asia-Pacific strategies is particularly worth noting. We are expanding the team to research the next wave of great stock opportunities. While emerging market returns may seem a bit pale compared to those in developed markets, Wim-Hein Pals explains in his outlook that there are plenty of good prospects across the various regions for 2025, at exceptionally low valuations. We believe there is a good chance that sentiment toward emerging markets may change after the new US administration takes over, when the discussion around tariffs will likely shift from threats to deals. We are completing our 2024 campaign ‘30 years of investing in Emerging Markets at Robeco’ with positive expectations.
With liquidity still abundant, best wishes for successful investments in 2025!
下載刊物
重要資料
本網站僅供《證券及期貨條例》(香港法例第571章)及其附屬法例所界定之專業投資者瀏覽及使用。 投資涉及風險。過往表現並不代表未來表現。本網站所載資料僅供參考之用,並不構成任何投資建議,亦非作出買賣任何證券或採納任何投資策略之要約或招攬。投資者不應僅憑本網站提供之資料作出投資決定,在作出任何投資決定前,應徵詢獨立意見(包括有關稅務影響之意見)。投資者應確保完全理解投資產品的相關風險,亦應考量自身投資目標及風險承受水平。投資乃閣下之個人決定。除非銷售投資產品的中介人已向閣下告知該投資產品適合閣下,並已解釋其符合閣下投資目標之原因,否則閣下不應投資。請參閱相關發售文件或其他法律文件,以獲取包括風險因素在內的進一步詳情。 本網站由荷寶投資管理香港有限公司發布,該公司受香港證券及期貨事務監察委員會(「證監會」)規管(中央編號:APU851)。本網站未經證監會審閱。 無法保證任何投資產品可實現其投資目標。概不就任何投資產品之表現或投資回報作任何聲明或承諾。投資的價值或會波動。本網站所載過往表現、推算或預測,均不應視作未來表現之保證或指標,且概不提供任何明示或暗示之保證。本網站內容建基於相信為可靠之來源,惟因應資料傳遞技術特性及須採用多項數據來源(包括第三方內容),故概不保證其準確性。所述觀點僅乃截至上述日期,或會隨市況變化而改變,可予更改而毋須另行通知。該等意見可能有別於其他荷寶投資專業人士之意見。因使用本材料或當中所載任何評論、意見或估算而引致之直接、間接或相應損失,荷寶概不承擔法律責任。荷寶並無責任更新本網站或任何網站內容。未經荷寶事先書面許可,不得複製、分發或刊發本網站任何材料。 除非另有說明,資料來源:荷寶。
































